Introduction
Acute Lymphoblastic Leukemia (ALL) is the most common 1 malignancy in children in Indonesia as well as in the world. Although 2 it has a high cure rate (80 -90%), if it is not treated, it can be fatal. In developing countries the mortality rate is higher, due to problems in diagnosis and limited access to chemotherapy. The diagnosis of ALL is based on the presence of leukemic cells (lymphoblasts) in circulation and definitely by the finding of more than 25% lymphoblast in the bone 12 marrow. At diagnosis, it is estimated that a number of 10 lymphoblasts develops and burdens the body, while at the end of the induction phase 10 3 about 10 leukemic cells still persist. The higher the rate of cytoreduction, the more successful the regimen eradicates the malignancy, as has been proven by the response to one week monotherapy and by minimal residual disease studies.
Many studies have shown a correlation of early response [4] [5] [6] [7] [8] [9] [10] [11] [12] to treatment with the prognosis of childhood ALL. Unfortunately, studies to measure residual disease or apoptotic cells as response to treatment in ALL need laboratory facilities such as flowcytometer, or PCR and those are not available in leukemia treatment centers [13] [14] in Indonesia.
To solve this problem, we used a simpler, cheaper and reproducible method to detect leukemic cells that undergo apoptosis during the induction phase of treatment. The basic idea is that apoptotic leukemic cells have a specific morphology that could be viewed under light microscope.
Apoptosis or programmed cell death is a series of genetically controlled events which result in the removal of unwanted cells without tissue disruption. It can be activated as response to relevant stimuli and it is characterized by distinct morphological and biochemical features. Morphologically, apoptotic cells will present with nuclear chromatin condensation, budding of the plasma membrane and finally by the production of membrane-bound apoptotic bodies. Since apoptosis is a way 15 of cell death that could be induced by chemotherapy, it is thought that the number of leukemic cells that undergo apoptosis may reflect drug sensitivity and its role in cytoreduction may correlate with prognosis. Previous studies have shown that apoptotic leukemic cells could be identified in the circulation during ALL treatment and this has a [16] [17] correlation with leukemic cell reduction. The purpose of this study was to detect apoptotic cells in peripheral blood of children with ALL during the first week of treatment.
Methods
We conducted a cross sectional study on 58 children with ALL between 0 -15 years treated with Wijaya Kusuma ALL (WK-ALL)-2000 protocol in Department of Child Health, Dr. Sardjito Hospital, Yogyakarta from March 1999 to May 2001. The WK-ALL-2000 protocol was designed to meet the Indonesia situation, adopted from the experience of childhood ALL treatment in USA and Europe consisted of 2 risk-based group i.e., standard-risk (SR) and high-risk (HR) patients. Patients whose WBC count 50,000/µl or more, age less than 1 year or 10 years or more and showed involvement of any site in the body (mediastinal, testicle, central nervous system) at the time of diagnosis were classified into HR patients. The inclusion criteria were children with newly diagnosed ALL (L1 or L2), without prior treatment for ALL, agreed to participate in this study. Informed consent was obtained from the parents or guardians.
Specimens of peripheral blood were taken during the first week of the 6 weeks remission induction consisted of one dose of intrathecal 2 methotrexate adjusted to the age, dexamethasone 6 mg/m /day in SR and HR patients plus 1 dose of daunorubicin for HR patients. At the first day of treatment, a blood smear was made at 3 hourly intervals and repeated every 24 hours for the second to seventh day. The smears were made from buffy-coat prepared by centrifugation of finger tip blood in heparinized Terumo capillary tubes at 2,500 rpm. Slides were stained with MayGrunwald Giemsa (Merck). Apoptotic cells were identified as small cells with nuclear condensation or apoptotic body formation (Figure 1) . The apoptotic cells were calculated as apoptotic index, i.e., the percentage of apoptotic cells among 200 mononuclear cells counted under light microscope.
Results
Apoptotic cells were identified in 3 patients at different time point of studies stated before ( Table 2 ). The apoptotic cells were observed at a range from 4.2% to 36.2%. Two patients showed a sharp decrease of WBC count in line with the decrease of lymphoblasts and increase of apoptotic cells percentage after 7 days treatment. Pt, patient; grouping: SR, standard risk, HR, high risk; d0-d7, peripheral blood before and at day-8 of treatment started; WBC , wh ite blood cell; Bl ast, blast numb er as percentage of WBC ; Apoptotic index, percentage of apoptotic cells in 200 mononuclear cells counted; h9, 9 hour after treatment; BMP d0, blast number in bone marrow before treatment started.
FAB, French-american-British classification for acute leukemia; Risk, patients risk-
FIGURE 1. Leukemic cells (lymphoblast) underwent apoptosis (arrow).
At 9 hours (A) and 3 hours (B) after treatment started in patient 1 and 3, respectively. Note the smaller size with nuclear condensation and apoptotic body formation.
Discussion
Until now only few studies had been performed to identify apoptosis during treatment response in childhood ALL, especially using 16 simple methods. Matsubara et al. found sharp declines of WBC and blast populations during chemotherapy treatment, but failed to identify apoptotic cells in the circulation using May Grunwald-Giemsa staining. 17 Tsangaris et al. used nuclear staining with ethidium bromide under fluorescent microscopy and found apoptotic cells in the circulation in various percentages, 24 hours after treatment. In comparison to the 17 methods used by , our method was simpler, using light microscope; May Grunwald-Giemsa staining was available easily in all hospital, without fractionation process and no more reagents and facilities needed.
Our study shows that apoptotic cells could be identified morphologically in the circulation, with the buffy-coat as a better source of mononuclear cells or lymphoblasts than that of a blood drop. During the first week of ALL treatment only sporadically apoptotic cells were recognizable in the peripheral blood, although the number of leukemic cells decreased sharply. The explanation of why we didn't find those cells in all smears or in the other 55 patients is still unclear. It may come from the situation where the apoptotic cells have been rapidly removed by phagocytes from the circulation or maybe our methods were not sensitive enough to detect small numbers of those cells in the circulation.
Another possibility might be there is certain machinery that 'prevent' apoptosis detection in in vivo.
In conclusion, our results showed that apoptotic cells can be detected with simple method from circulation, especially on slides obtained from buffy coats. However, in most patients no apoptotic cells were seen, though the number of leukemic cells in the circulation decreased rapidly. Apparently, cell death through apoptosis is a process that takes place outside the circulation, or apoptotic cells are rapidly taken out from the circulation.
